The Adherence of Proactive Sleep Apnea Therapy - Trial NCT06319482
Access comprehensive clinical trial information for NCT06319482 through Pure Global AI's free database. This phase not specified trial is sponsored by NovaResp Technologies Inc and is currently Not yet recruiting. The study focuses on Obstructive Sleep Apnea. Target enrollment is 200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
NovaResp Technologies Inc
Timeline & Enrollment
N/A
Jun 01, 2024
Aug 01, 2025
Primary Outcome
Adherence
Summary
The goal of this clinical trial is to compare the adherence to Positive Airway Pressure (PAP)
 therapy for newly diagnosed Obstructive Sleep Apnea (OSA) patients. The main question(s) it
 aims to answer are:
 
 1. To compare the adherence of proactive therapy and conventional Automatic-PAP (APAP)
 therapy short-term (3 months) and long-term (12 months) for newly diagnosed OSA
 patients.
 
 2. To compare health outcomes (AHI, nightly pressure, and patient-reported outcomes)
 between proactive therapy and conventional APAP therapy.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06319482
Device Trial